QA: ENDONOVO THERAPEUTICS INC. in us_pharma/2020

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001528172_2021_ENDONOVO_THERAPEUTICS_INC.pdf

Logs

warning Missing logo subcommand.report {}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001528172')"}

Graph

Absolute values for 0001528172, ENDONOVO THERAPEUTICS INC.

  xvar xval
0 AssetsCurrent 46,187
1 IntangibleAssetsNetIncludingGoodwill 2,559,268
2 PropertyPlantAndEquipmentNet 1,580
3 remainder_Assets 0
4 LiabilitiesCurrent 16,825,821
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 155,000
7 CostOfGoodsAndServicesSold 65,369
8 SellingGeneralAndAdministrativeExpense 0
9 ResearchAndDevelopmentExpense 0
10 remainder_Expenses 3,012,625
11 remainder_Revenues 165,796
12 remainder_NetIncome 2,516,614
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 2,607,035
1 Liabilities 16,980,821
2 Expenses 3,077,994
3 Revenues 165,796
4 StockholdersEquity -14,373,786
5 NetIncome -395,584
6 ComprehensiveNetIncome -395,584
7 BaseVar 12,674,130
8 EconomicCapitalRatio -2.56

Edgar->Model Mapping

Feature Distribution

Change over Time